Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.

Barcenas, Carlos H; Raghavendra, Akshara; Sinha, Arup K; Syed, Masood Pasha; Hsu, Limin; Patangan, Modesto G; Chavez-MacGregor, Mariana; Shen, Yu; Hortobagyi, Gabriel H; Valero, Vicente; Giordano, Sharon H; Ueno, Naoto T; Tripathy, Debu

Barcenas, Carlos H; Raghavendra, Akshara; Sinha, Arup K; Syed, Masood Pasha; Hsu, Limin; Patangan, Modesto G; Chavez-MacGregor, Mariana; Shen, Yu; Hortobagyi, Gabriel H; Valero, Vicente; Giordano, Sharon H; Ueno, Naoto T; Tripathy, Debu.

Afiliación

Barcenas CH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Raghavendra A; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sinha AK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Syed MP; Department of Biostatistics, The University of Texas School of Public Health, Houston, Texas.
Hsu L; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Patangan MG; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Chavez-MacGregor M; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Shen Y; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hortobagyi GH; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Valero V; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Giordano SH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ueno NT; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Cancer ; 123(13): 2422-2431, 2017 Jul 01.

Article en En | MEDLINE | ID: mdl-28199747

Asunto(s)

Neoplasias de la Mama/genética; Carcinoma Ductal de Mama/genética; Carcinoma Lobular/genética; Expresión Génica/genética; Adulto; Anciano; Antineoplásicos/uso terapéutico; Antineoplásicos Hormonales/uso terapéutico; Neoplasias de la Mama/metabolismo; Neoplasias de la Mama/patología; Neoplasias de la Mama/terapia; Carcinoma Ductal de Mama/metabolismo; Carcinoma Ductal de Mama/patología; Carcinoma Ductal de Mama/terapia; Carcinoma Lobular/metabolismo; Carcinoma Lobular/patología; Carcinoma Lobular/terapia; Supervivencia sin Enfermedad; Femenino; Perfilación de la Expresión Génica; Humanos; Estimación de Kaplan-Meier; Mastectomía; Persona de Mediana Edad; Análisis Multivariante; Estadificación de Neoplasias; Pronóstico; Modelos de Riesgos Proporcionales; Radioterapia; Receptor ErbB-2/metabolismo; Receptores de Estrógenos/metabolismo; Receptores de Progesterona/metabolismo; Estudios Retrospectivos; Tasa de Supervivencia; Carga Tumoral; Adulto Joven

Palabras clave

chemotherapy; early-stage breast cancer; gene expression assays; hormone receptor positive; tumor genomics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Expresión Génica / Carcinoma Lobular / Carcinoma Ductal de Mama Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google